Medimaps Group raises CHF 18.55 million
1 December 2021 – Walder Wyss has advised Swisscanto Invest by Zürcher Kantonalbank in connection with medimaps group’s Series C Financing round in the amount of CHF 18.55 mio. Swisscanto Invest invests on behalf of its clients in Swiss growth companies in the expansion phase. medimaps group is dedicated to the conception, development, manufacture and marketing of software in the healthcare sector, in particular in the field of texture bone analysis.
The Walder Wyss team was led by Alexandre Both (Partner, Corporate/M&A) and included Alex Nikitine (Partner, Corporate/M&A), Grégoire Henriod (Senior Associate, Corporate/M&A), Aurélien Bill (Senior Associate, Corporate/Employment) and Riccardo Brazerol (Associate, Corporate/M&A).